Advert - Galderma

For sending promotional emails without the prior permission of the recipients, Galderma was ruled in breach of the following clauses of the Code:

Clause 9.1 - Failing to maintain high standards

Clause 9.9 - Failing to obtain prior permission from the recipients to send promotional emails.

The Code of Practice Panel ruled no breach of Clause 2 as the matters were not such as to bring discredit upon or reduce confidence in the pharmaceutical industry. The Panel was concerned about the difficulty in obtaining the relevant information from Galderma and considered that its responses demonstrated a general lack of understanding of the applicability of the Code.

The Panel reported Galderma to the Code of Practice Appeal Board which publicly reprimanded the company; it also required an audit of Galderma’s procedures.

Galderma subsequently declined the audit and indicated that it no longer wished to accept the jurisdiction of the Authority.

The Appeal Board removed Galderma from the list of non member companies that have agreed to comply with the Code and accept the jurisdiction of the Authority.

The PMCPA thus can no longer accept responsibility for Galderma under the Code.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has been so informed.